{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T04:56:57Z","timestamp":1781240217348,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,3,30]],"date-time":"2013-03-30T00:00:00Z","timestamp":1364601600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s11095-013-1017-4","type":"journal-article","created":{"date-parts":[[2013,3,29]],"date-time":"2013-03-29T17:57:31Z","timestamp":1364579851000},"page":"1749-1757","source":"Crossref","is-referenced-by-count":34,"title":["Non-Aqueous Suspensions of Antibodies are Much Less Viscous Than Equally Concentrated Aqueous Solutions"],"prefix":"10.1007","volume":"30","author":[{"given":"Charudharshini","family":"Srinivasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisha K.","family":"Weight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Bussemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Klibanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,30]]},"reference":[{"key":"1017_CR1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nri2747","volume":"10","author":"A Beck","year":"2010","unstructured":"Beck A, Wurch T, Bailly C, Corvaia N. Strategies and challenges for the next generation of therapeutic antibodies. Nature Revs Immunol. 2010;10:345\u201352.","journal-title":"Nature Revs Immunol"},{"key":"1017_CR2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nri2744","volume":"10","author":"LM Weiner","year":"2010","unstructured":"Weiner LM, Surana R, Wang S. Monoclonal antibodies: versatile platforms for cancer immunotherapy. Nature Revs Immunol. 2010;10:317\u201327.","journal-title":"Nature Revs Immunol"},{"key":"1017_CR3","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1529\/biophysj.106.098293","volume":"93","author":"T Ahamed","year":"2007","unstructured":"Ahamed T, Esteban BNA, Ottens M, van Dedem GWK, van der Wielen LAM, Bisschops MAT, et al. Phase behavior of an intact monoclonal antibody. Biophys J. 2007;93:610\u20139.","journal-title":"Biophys J"},{"key":"1017_CR4","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1073\/pnas.1131899100","volume":"100","author":"MX Yang","year":"2003","unstructured":"Yang MX, Shenoy B, Disttler M, Patel R, McGrath M, Pechenov S, et al. Crystalline monoclonal antibodies for subcutaneous delivery. Proc Natl Acad Sci U S A. 2003;100:6934\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1017_CR5","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/jps.20079","volume":"93","author":"SJ Shire","year":"2004","unstructured":"Shire SJ, Shahrokh Z, Liu J. Challenges in the development of high protein concentration formulations. J Pharm Sci. 2004;93:1390\u2013402.","journal-title":"J Pharm Sci"},{"key":"1017_CR6","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/bit.22983","volume":"108","author":"W Du","year":"2011","unstructured":"Du W, Klibanov AM. Hydrophobic salts markedly diminish viscosity of concentrated protein solutions. Biotechnol Bioeng. 2011;108:632\u20136.","journal-title":"Biotechnol Bioeng"},{"key":"1017_CR7","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1007\/s11095-012-0802-9","volume":"29","author":"Z Guo","year":"2012","unstructured":"Guo Z, Chen A, Nassar RA, Helk B, Mueller C, Tang Y, et al. Structure-activity relationship for hydrophobic salts as viscosity-lowering excipients for concentrated solutions of monoclonal antibodies. Pharm Res. 2012;29:3102\u20139.","journal-title":"Pharm Res"},{"key":"1017_CR8","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1021\/la9023426","volume":"26","author":"MA Miller","year":"2010","unstructured":"Miller MA, Engstrom JD, Ludher BS, Johnston KP. Low viscosity highly concentrated injectable nonaqueous suspension of lysozyme microparticles. Langmuir. 2010;26:1067\u201374.","journal-title":"Langmuir"},{"key":"1017_CR9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1021\/nn204166z","volume":"6","author":"KP Johnston","year":"2012","unstructured":"Johnston KP, Maynard JA, Truskett TM, Borwankar AU, Miller MA, Wilson BK, et al. Concentrated dispersion of equilibrium protein nanoclusters that reversibly dissociate into active monomers. ACS Nano. 2012;6:1357\u201369.","journal-title":"ACS Nano"},{"key":"1017_CR10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1517\/14712598.4.3.301","volume":"4","author":"SK Basu","year":"2004","unstructured":"Basu SK, Govardhan CP, Jung CW, Margolin AL. Protein crystals for the delivery of biopharmaceuticals. Expert Op Biol Ther. 2004;4:301\u201317.","journal-title":"Expert Op Biol Ther"},{"key":"1017_CR11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ab.2009.12.003","volume":"399","author":"F He","year":"2010","unstructured":"He F, Becker GW, Litowski JR, Narhi LO, Brems DN, Razinkov VI. High throughput dynamic light scattering methods for measuring viscosity of concentrated protein solutions. Anal Biochem. 2010;399:141\u20133.","journal-title":"Anal Biochem"},{"key":"1017_CR12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1122\/1.548848","volume":"3","author":"IM Krieger","year":"1959","unstructured":"Krieger IM, Dougherty TJ. A mechanism for non-Newtonian flow in suspensions of rigid spheres. Trans Soc Rheol. 1959;3:137\u201352.","journal-title":"Trans Soc Rheol"},{"key":"1017_CR13","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1002\/jps.21610","volume":"98","author":"AR Patel","year":"2009","unstructured":"Patel AR, Kerwin BA, Kanapuram SR. Viscoelastic characterization of high concentration antibody formulations using quartz crystal microbalance with dissipation monitoring. J Pharm Sci. 2009;98:3108\u201316.","journal-title":"J Pharm Sci"},{"key":"1017_CR14","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1002\/jps.21322","volume":"97","author":"S Kanai","year":"2008","unstructured":"Kanai S, Liu J, Patapoff HW, Shire SJ. Reversible self-association of a concentrated monoclonal antibody solution mediated by Fab-Fab interaction that impacts solution viscosity. J Pharm Sci. 2008;97:4219\u201327.","journal-title":"J Pharm Sci"},{"key":"1017_CR15","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1002\/jps.22190","volume":"99","author":"S Yadav","year":"2010","unstructured":"Yadav S, Shire SJ, Kalonia DS. Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies. J Pharm Sci. 2010;99:4812\u201329.","journal-title":"J Pharm Sci"},{"key":"1017_CR16","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1128\/JB.186.15.5129-5137.2004","volume":"186","author":"HM Patel","year":"2004","unstructured":"Patel HM, Kraszewski JL, Mukhopadhyay B. The phosphoenolpyruvate carboxylase from Methanothermobacter thermautotrophicus has a novel structure. J Bacteriol. 2004;186:5129\u201337.","journal-title":"J Bacteriol"},{"key":"1017_CR17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0076-6879(90)82024-V","volume":"182","author":"S Englard","year":"1990","unstructured":"Englard S, Seifter S. Precipitation techniques. Meth Enzymol. 1990;182:285\u2013300.","journal-title":"Meth Enzymol"},{"key":"1017_CR18","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/jps.21526","volume":"98","author":"S Matheus","year":"2009","unstructured":"Matheus S, Friess W, Schwartz D, Mahler H-C. Liquid high concentration IgG1 antibody formulations by precipitation. J Pharm Sci. 2009;98:3043\u201357.","journal-title":"J Pharm Sci"},{"key":"1017_CR19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrd1695","volume":"4","author":"S Frokjaer","year":"2005","unstructured":"Frokjaer S, Otzen DE. Protein drug stability: a formulation challenge. Nature Revs Drug Discov. 2005;4:298\u2013306.","journal-title":"Nature Revs Drug Discov"},{"key":"1017_CR20","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.1007\/BF01025606","volume":"8","author":"CJ Oss Van","year":"1989","unstructured":"Van Oss CJ. On the mechanism of the cold ethanol precipitation method of plasma protein fractionation. J Protein Chem. 1989;8:6661\u20138.","journal-title":"J Protein Chem"},{"key":"1017_CR21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/35051719","volume":"409","author":"AM Klibanov","year":"2001","unstructured":"Klibanov AM. Improving enzymes by using them in organic solvents. Nature. 2001;409:241\u20136.","journal-title":"Nature"},{"key":"1017_CR22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0168-3659(96)01623-9","volume":"47","author":"TP Foster","year":"1997","unstructured":"Foster TP, Moseley WM, Caputo JF, Alaniz GR, Leatherman MW, Yu X, et al. Sustained elevated serum somatotropin concentrations in Holstein steers following subcutaneous delivery of a growth hormone releasing factor analog dispersed in water, oil or microspheres. J Control Rel. 1997;47:91\u20139.","journal-title":"J Control Rel"},{"key":"1017_CR23","unstructured":"FDA. Inactive ingredient search for approved drug products. November 23, 2012. Available from: http:\/\/www.accessdata.fda.gov\/scripts\/cder\/iig\/index.cfm ."},{"key":"1017_CR24","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1002\/jps.23324","volume":"101","author":"M Bowen","year":"2012","unstructured":"Bowen M, Armstrong N, Ma Y-F. Investigating high-concentration monoclonal antibody powder suspension in nonaqueous suspension vehicles for subcutaneous injection. J Pharm Sci. 2012;101:4433\u201343.","journal-title":"J Pharm Sci"},{"key":"1017_CR25","unstructured":"Dai W, Hill B, Liu K, Mieczkowski C. Non-aqueous high concentration reduced viscosity suspension formulations of antibodies. US Patent Application 2012; 0 076 800."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-013-1017-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-013-1017-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-013-1017-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T05:54:32Z","timestamp":1559368472000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-013-1017-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,30]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["1017"],"URL":"https:\/\/doi.org\/10.1007\/s11095-013-1017-4","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,30]]}}}